Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 3
2018 2
2019 4
2020 3
2021 1
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission.
Lawler M, Davies L, Oberst S, Oliver K, Eggermont A, Schmutz A, La Vecchia C, Allemani C, Lievens Y, Naredi P, Cufer T, Aggarwal A, Aapro M, Apostolidis K, Baird AM, Cardoso F, Charalambous A, Coleman MP, Costa A, Crul M, Dégi CL, Di Nicolantonio F, Erdem S, Geanta M, Geissler J, Jassem J, Jagielska B, Jonsson B, Kelly D, Kelm O, Kolarova T, Kutluk T, Lewison G, Meunier F, Pelouchova J, Philip T, Price R, Rau B, Rubio IT, Selby P, Južnič Sotlar M, Spurrier-Bernard G, van Hoeve JC, Vrdoljak E, Westerhuis W, Wojciechowska U, Sullivan R. Lawler M, et al. Among authors: apostolidis k. Lancet Oncol. 2023 Jan;24(1):e11-e56. doi: 10.1016/S1470-2045(22)00540-X. Epub 2022 Nov 16. Lancet Oncol. 2023. PMID: 36400101 Review.
Liquid biopsies, are we ready for prime time?
Normanno N, Apostolidis K, Stewart M. Normanno N, et al. Among authors: apostolidis k. J Immunother Cancer. 2023 Feb;11(2):e006302. doi: 10.1136/jitc-2022-006302. J Immunother Cancer. 2023. PMID: 36796879 Free PMC article. No abstract available.
Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?
Horgan D, Spanic T, Apostolidis K, Curigliano G, Chorostowska-Wynimko J, Dauben HP, Lal JA, Dziadziuszko R, Mayer-Nicolai C, Kozaric M, Jönsson B, Gutierrez-Ibarluzea I, Fandel MH, Lopert R. Horgan D, et al. Among authors: apostolidis k. Healthcare (Basel). 2022 Aug 22;10(8):1594. doi: 10.3390/healthcare10081594. Healthcare (Basel). 2022. PMID: 36011250 Free PMC article.
Towards a cancer mission in Horizon Europe: recommendations.
Berns A, Ringborg U, Celis JE, Heitor M, Aaronson NK, Abou-Zeid N, Adami HO, Apostolidis K, Baumann M, Bardelli A, Bernards R, Brandberg Y, Caldas C, Calvo F, Dive C, Eggert A, Eggermont A, Espina C, Falkenburg F, Foucaud J, Hanahan D, Helbig U, Jönsson B, Kalager M, Karjalainen S, Kásler M, Kearns P, Kärre K, Lacombe D, de Lorenzo F, Meunier F, Nettekoven G, Oberst S, Nagy P, Philip T, Price R, Schüz J, Solary E, Strang P, Tabernero J, Voest E. Berns A, et al. Among authors: apostolidis k. Mol Oncol. 2020 Aug;14(8):1589-1615. doi: 10.1002/1878-0261.12763. Mol Oncol. 2020. PMID: 32749074 Free PMC article.
Access and quality of biomarker testing for precision oncology in Europe.
Normanno N, Apostolidis K, Wolf A, Al Dieri R, Deans Z, Fairley J, Maas J, Martinez A, Moch H, Nielsen S, Pilz T, Rouleau E, Patton S, Williams V. Normanno N, et al. Among authors: apostolidis k. Eur J Cancer. 2022 Nov;176:70-77. doi: 10.1016/j.ejca.2022.09.005. Epub 2022 Oct 1. Eur J Cancer. 2022. PMID: 36194905 Free article.
Learning from data to predict future symptoms of oncology patients.
Papachristou N, Puschmann D, Barnaghi P, Cooper B, Hu X, Maguire R, Apostolidis K, Conley YP, Hammer M, Katsaragakis S, Kober KM, Levine JD, McCann L, Patiraki E, Furlong EP, Fox PA, Paul SM, Ream E, Wright F, Miaskowski C. Papachristou N, et al. Among authors: apostolidis k. PLoS One. 2018 Dec 31;13(12):e0208808. doi: 10.1371/journal.pone.0208808. eCollection 2018. PLoS One. 2018. PMID: 30596658 Free PMC article. Clinical Trial.
20 results